カテゴリー： 世界, 医療/バイオ, LP Information

世界のNEU3抗体市場予測 2023年-2029年

【英語タイトル】Global NEU3 Antibody Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08024）・商品コード：LP23DC08024
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のNEU3抗体市場」は、過去の販売実績から2022年の世界のNEU3抗体の総販売量を検討し、2023年から2029年の予測されるNEU3抗体の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のNEU3抗体の市場規模を掲載し、XXX百万米ドル規模の世界のNEU3抗体市場の詳細な分析を提供します。本インサイトレポートは、世界のNEU3抗体業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のNEU3抗体市場における各社の独自のポジションをより深く理解するために、NEU3抗体製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のNEU3抗体市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。NEU3抗体の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。NEU3抗体の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。NEU3抗体のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

NEU3抗体の世界主要メーカーとしては、Merck、 Thermo Fisher Scientific、 Aviva Systems Biology、 Biomatik、 LifeSpan BioSciences、 ProSci、 Novus Biologicals、 OriGene Technologies、 Proteintech Group、 CUSABIO Technology、 Abcam、 EpiGentek、 Leading Biology、 United States Biological、 Creative Diagnostics、 Biobyt、 Jingjie PTM BioLabなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のNEU3抗体市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではNEU3抗体市場をセグメンテーションし、種類別 (モノクローナル、ポリクローナル)、用途別 (免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：モノクローナル、ポリクローナル

・用途別区分：免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のNEU3抗体市場の10年間の市場状況・展望は？
・世界および地域別に見たNEU3抗体市場成長の要因は何か？
・NEU3抗体の市場機会はエンドマーケットの規模によってどのように変化するのか？
・NEU3抗体のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：NEU3抗体の年間販売量2018-2029、地域別現状・将来分析
・NEU3抗体の種類別セグメント：モノクローナル、ポリクローナル
・NEU3抗体の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・NEU3抗体の用途別セグメント：免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他
・NEU3抗体の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のNEU3抗体市場
・企業別のグローバルNEU3抗体市場データ：2018-2023年の年間販売量、市場シェア
・企業別のNEU3抗体の年間売上：2018-2023年の売上、市場シェア
・企業別のNEU3抗体販売価格
・主要企業のNEU3抗体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

NEU3抗体の地域別レビュー
・地域別のNEU3抗体市場規模2018-2023：年間販売量、売上
・主要国別のNEU3抗体市場規模2018-2023：年間販売量、売上
・南北アメリカのNEU3抗体販売の成長
・アジア太平洋のNEU3抗体販売の成長
・ヨーロッパのNEU3抗体販売の成長
・中東・アフリカのNEU3抗体販売の成長

南北アメリカ市場
・南北アメリカの国別のNEU3抗体販売量、売上（2018-2023）
・南北アメリカのNEU3抗体の種類別販売量
・南北アメリカのNEU3抗体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のNEU3抗体販売量、売上（2018-2023）
・アジア太平洋のNEU3抗体の種類別販売量
・アジア太平洋のNEU3抗体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のNEU3抗体販売量、売上（2018-2023）
・ヨーロッパのNEU3抗体の種類別販売量
・ヨーロッパのNEU3抗体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のNEU3抗体販売量、売上（2018-2023）
・中東・アフリカのNEU3抗体の種類別販売量
・中東・アフリカのNEU3抗体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・NEU3抗体の製造コスト構造分析
・NEU3抗体の製造プロセス分析
・NEU3抗体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・NEU3抗体の主要なグローバル販売業者
・NEU3抗体の主要なグローバル顧客

地域別のNEU3抗体市場予測レビュー
・地域別のNEU3抗体市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・NEU3抗体の種類別市場規模予測
・NEU3抗体の用途別市場規模予測

主要企業分析
Merck、 Thermo Fisher Scientific、 Aviva Systems Biology、 Biomatik、 LifeSpan BioSciences、 ProSci、 Novus Biologicals、 OriGene Technologies、 Proteintech Group、 CUSABIO Technology、 Abcam、 EpiGentek、 Leading Biology、 United States Biological、 Creative Diagnostics、 Biobyt、 Jingjie PTM BioLab
・企業情報
・NEU3抗体製品
・NEU3抗体販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global NEU3 Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Growing patient base, launch of NEU3 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in NEU3 antibody market revenue.
The NEU3 gene product belongs to a family of glycohydrolytic enzymes which remove sialic acid residues from glycoproteins and glycolipids.The NEU3 antibody is specific for the C Terminus Region of the target protein.
LPI (LP Information)’ newest research report, the “NEU3 Antibody Industry Forecast” looks at past sales and reviews total world NEU3 Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected NEU3 Antibody sales for 2023 through 2029. With NEU3 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NEU3 Antibody industry.
This Insight Report provides a comprehensive analysis of the global NEU3 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NEU3 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NEU3 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NEU3 Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NEU3 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of NEU3 Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Monoclonal
Polyclonal
Segmentation by application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
Thermo Fisher Scientific
Aviva Systems Biology
Biomatik
LifeSpan BioSciences
ProSci
Novus Biologicals
OriGene Technologies
Proteintech Group
CUSABIO Technology
Abcam
EpiGentek
Leading Biology
United States Biological
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Key Questions Addressed in this Report
What is the 10-year outlook for the global NEU3 Antibody market?
What factors are driving NEU3 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NEU3 Antibody market opportunities vary by end market size?
How does NEU3 Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NEU3 Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for NEU3 Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for NEU3 Antibody by Country/Region, 2018, 2022 & 2029
2.2 NEU3 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.3 NEU3 Antibody Sales by Type
2.3.1 Global NEU3 Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global NEU3 Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global NEU3 Antibody Sale Price by Type (2018-2023)
2.4 NEU3 Antibody Segment by Application
2.4.1 Immunochemistry (IHC)
2.4.2 Immunofluorescence (IF)
2.4.3 Immunoprecipitation (IP)
2.4.4 Western Blot (WB)
2.4.5 ELISA
2.4.6 Others
2.5 NEU3 Antibody Sales by Application
2.5.1 Global NEU3 Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global NEU3 Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global NEU3 Antibody Sale Price by Application (2018-2023)
3 Global NEU3 Antibody by Company
3.1 Global NEU3 Antibody Breakdown Data by Company
3.1.1 Global NEU3 Antibody Annual Sales by Company (2018-2023)
3.1.2 Global NEU3 Antibody Sales Market Share by Company (2018-2023)
3.2 Global NEU3 Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global NEU3 Antibody Revenue by Company (2018-2023)
3.2.2 Global NEU3 Antibody Revenue Market Share by Company (2018-2023)
3.3 Global NEU3 Antibody Sale Price by Company
3.4 Key Manufacturers NEU3 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NEU3 Antibody Product Location Distribution
3.4.2 Players NEU3 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NEU3 Antibody by Geographic Region
4.1 World Historic NEU3 Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global NEU3 Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global NEU3 Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic NEU3 Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global NEU3 Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global NEU3 Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas NEU3 Antibody Sales Growth
4.4 APAC NEU3 Antibody Sales Growth
4.5 Europe NEU3 Antibody Sales Growth
4.6 Middle East & Africa NEU3 Antibody Sales Growth
5 Americas
5.1 Americas NEU3 Antibody Sales by Country
5.1.1 Americas NEU3 Antibody Sales by Country (2018-2023)
5.1.2 Americas NEU3 Antibody Revenue by Country (2018-2023)
5.2 Americas NEU3 Antibody Sales by Type
5.3 Americas NEU3 Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NEU3 Antibody Sales by Region
6.1.1 APAC NEU3 Antibody Sales by Region (2018-2023)
6.1.2 APAC NEU3 Antibody Revenue by Region (2018-2023)
6.2 APAC NEU3 Antibody Sales by Type
6.3 APAC NEU3 Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NEU3 Antibody by Country
7.1.1 Europe NEU3 Antibody Sales by Country (2018-2023)
7.1.2 Europe NEU3 Antibody Revenue by Country (2018-2023)
7.2 Europe NEU3 Antibody Sales by Type
7.3 Europe NEU3 Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NEU3 Antibody by Country
8.1.1 Middle East & Africa NEU3 Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa NEU3 Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa NEU3 Antibody Sales by Type
8.3 Middle East & Africa NEU3 Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NEU3 Antibody
10.3 Manufacturing Process Analysis of NEU3 Antibody
10.4 Industry Chain Structure of NEU3 Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NEU3 Antibody Distributors
11.3 NEU3 Antibody Customer
12 World Forecast Review for NEU3 Antibody by Geographic Region
12.1 Global NEU3 Antibody Market Size Forecast by Region
12.1.1 Global NEU3 Antibody Forecast by Region (2024-2029)
12.1.2 Global NEU3 Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global NEU3 Antibody Forecast by Type
12.7 Global NEU3 Antibody Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck NEU3 Antibody Product Portfolios and Specifications
13.1.3 Merck NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific NEU3 Antibody Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Aviva Systems Biology
13.3.1 Aviva Systems Biology Company Information
13.3.2 Aviva Systems Biology NEU3 Antibody Product Portfolios and Specifications
13.3.3 Aviva Systems Biology NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aviva Systems Biology Main Business Overview
13.3.5 Aviva Systems Biology Latest Developments
13.4 Biomatik
13.4.1 Biomatik Company Information
13.4.2 Biomatik NEU3 Antibody Product Portfolios and Specifications
13.4.3 Biomatik NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Biomatik Main Business Overview
13.4.5 Biomatik Latest Developments
13.5 LifeSpan BioSciences
13.5.1 LifeSpan BioSciences Company Information
13.5.2 LifeSpan BioSciences NEU3 Antibody Product Portfolios and Specifications
13.5.3 LifeSpan BioSciences NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LifeSpan BioSciences Main Business Overview
13.5.5 LifeSpan BioSciences Latest Developments
13.6 ProSci
13.6.1 ProSci Company Information
13.6.2 ProSci NEU3 Antibody Product Portfolios and Specifications
13.6.3 ProSci NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ProSci Main Business Overview
13.6.5 ProSci Latest Developments
13.7 Novus Biologicals
13.7.1 Novus Biologicals Company Information
13.7.2 Novus Biologicals NEU3 Antibody Product Portfolios and Specifications
13.7.3 Novus Biologicals NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novus Biologicals Main Business Overview
13.7.5 Novus Biologicals Latest Developments
13.8 OriGene Technologies
13.8.1 OriGene Technologies Company Information
13.8.2 OriGene Technologies NEU3 Antibody Product Portfolios and Specifications
13.8.3 OriGene Technologies NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 OriGene Technologies Main Business Overview
13.8.5 OriGene Technologies Latest Developments
13.9 Proteintech Group
13.9.1 Proteintech Group Company Information
13.9.2 Proteintech Group NEU3 Antibody Product Portfolios and Specifications
13.9.3 Proteintech Group NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Proteintech Group Main Business Overview
13.9.5 Proteintech Group Latest Developments
13.10 CUSABIO Technology
13.10.1 CUSABIO Technology Company Information
13.10.2 CUSABIO Technology NEU3 Antibody Product Portfolios and Specifications
13.10.3 CUSABIO Technology NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 CUSABIO Technology Main Business Overview
13.10.5 CUSABIO Technology Latest Developments
13.11 Abcam
13.11.1 Abcam Company Information
13.11.2 Abcam NEU3 Antibody Product Portfolios and Specifications
13.11.3 Abcam NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Abcam Main Business Overview
13.11.5 Abcam Latest Developments
13.12 EpiGentek
13.12.1 EpiGentek Company Information
13.12.2 EpiGentek NEU3 Antibody Product Portfolios and Specifications
13.12.3 EpiGentek NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 EpiGentek Main Business Overview
13.12.5 EpiGentek Latest Developments
13.13 Leading Biology
13.13.1 Leading Biology Company Information
13.13.2 Leading Biology NEU3 Antibody Product Portfolios and Specifications
13.13.3 Leading Biology NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Leading Biology Main Business Overview
13.13.5 Leading Biology Latest Developments
13.14 United States Biological
13.14.1 United States Biological Company Information
13.14.2 United States Biological NEU3 Antibody Product Portfolios and Specifications
13.14.3 United States Biological NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 United States Biological Main Business Overview
13.14.5 United States Biological Latest Developments
13.15 Creative Diagnostics
13.15.1 Creative Diagnostics Company Information
13.15.2 Creative Diagnostics NEU3 Antibody Product Portfolios and Specifications
13.15.3 Creative Diagnostics NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Creative Diagnostics Main Business Overview
13.15.5 Creative Diagnostics Latest Developments
13.16 Biobyt
13.16.1 Biobyt Company Information
13.16.2 Biobyt NEU3 Antibody Product Portfolios and Specifications
13.16.3 Biobyt NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Biobyt Main Business Overview
13.16.5 Biobyt Latest Developments
13.17 Jingjie PTM BioLab
13.17.1 Jingjie PTM BioLab Company Information
13.17.2 Jingjie PTM BioLab NEU3 Antibody Product Portfolios and Specifications
13.17.3 Jingjie PTM BioLab NEU3 Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jingjie PTM BioLab Main Business Overview
13.17.5 Jingjie PTM BioLab Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. NEU3 Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. NEU3 Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global NEU3 Antibody Sales by Type (2018-2023) & (ml)
Table 6. Global NEU3 Antibody Sales Market Share by Type (2018-2023)
Table 7. Global NEU3 Antibody Revenue by Type (2018-2023) & ($ million)
Table 8. Global NEU3 Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global NEU3 Antibody Sale Price by Type (2018-2023) & (US$/ml)
Table 10. Global NEU3 Antibody Sales by Application (2018-2023) & (ml)
Table 11. Global NEU3 Antibody Sales Market Share by Application (2018-2023)
Table 12. Global NEU3 Antibody Revenue by Application (2018-2023)
Table 13. Global NEU3 Antibody Revenue Market Share by Application (2018-2023)
Table 14. Global NEU3 Antibody Sale Price by Application (2018-2023) & (US$/ml)
Table 15. Global NEU3 Antibody Sales by Company (2018-2023) & (ml)
Table 16. Global NEU3 Antibody Sales Market Share by Company (2018-2023)
Table 17. Global NEU3 Antibody Revenue by Company (2018-2023) ($ Millions)
Table 18. Global NEU3 Antibody Revenue Market Share by Company (2018-2023)
Table 19. Global NEU3 Antibody Sale Price by Company (2018-2023) & (US$/ml)
Table 20. Key Manufacturers NEU3 Antibody Producing Area Distribution and Sales Area
Table 21. Players NEU3 Antibody Products Offered
Table 22. NEU3 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global NEU3 Antibody Sales by Geographic Region (2018-2023) & (ml)
Table 26. Global NEU3 Antibody Sales Market Share Geographic Region (2018-2023)
Table 27. Global NEU3 Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global NEU3 Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global NEU3 Antibody Sales by Country/Region (2018-2023) & (ml)
Table 30. Global NEU3 Antibody Sales Market Share by Country/Region (2018-2023)
Table 31. Global NEU3 Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global NEU3 Antibody Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas NEU3 Antibody Sales by Country (2018-2023) & (ml)
Table 34. Americas NEU3 Antibody Sales Market Share by Country (2018-2023)
Table 35. Americas NEU3 Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas NEU3 Antibody Revenue Market Share by Country (2018-2023)
Table 37. Americas NEU3 Antibody Sales by Type (2018-2023) & (ml)
Table 38. Americas NEU3 Antibody Sales by Application (2018-2023) & (ml)
Table 39. APAC NEU3 Antibody Sales by Region (2018-2023) & (ml)
Table 40. APAC NEU3 Antibody Sales Market Share by Region (2018-2023)
Table 41. APAC NEU3 Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC NEU3 Antibody Revenue Market Share by Region (2018-2023)
Table 43. APAC NEU3 Antibody Sales by Type (2018-2023) & (ml)
Table 44. APAC NEU3 Antibody Sales by Application (2018-2023) & (ml)
Table 45. Europe NEU3 Antibody Sales by Country (2018-2023) & (ml)
Table 46. Europe NEU3 Antibody Sales Market Share by Country (2018-2023)
Table 47. Europe NEU3 Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe NEU3 Antibody Revenue Market Share by Country (2018-2023)
Table 49. Europe NEU3 Antibody Sales by Type (2018-2023) & (ml)
Table 50. Europe NEU3 Antibody Sales by Application (2018-2023) & (ml)
Table 51. Middle East & Africa NEU3 Antibody Sales by Country (2018-2023) & (ml)
Table 52. Middle East & Africa NEU3 Antibody Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa NEU3 Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa NEU3 Antibody Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa NEU3 Antibody Sales by Type (2018-2023) & (ml)
Table 56. Middle East & Africa NEU3 Antibody Sales by Application (2018-2023) & (ml)
Table 57. Key Market Drivers & Growth Opportunities of NEU3 Antibody
Table 58. Key Market Challenges & Risks of NEU3 Antibody
Table 59. Key Industry Trends of NEU3 Antibody
Table 60. NEU3 Antibody Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. NEU3 Antibody Distributors List
Table 63. NEU3 Antibody Customer List
Table 64. Global NEU3 Antibody Sales Forecast by Region (2024-2029) & (ml)
Table 65. Global NEU3 Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas NEU3 Antibody Sales Forecast by Country (2024-2029) & (ml)
Table 67. Americas NEU3 Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC NEU3 Antibody Sales Forecast by Region (2024-2029) & (ml)
Table 69. APAC NEU3 Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe NEU3 Antibody Sales Forecast by Country (2024-2029) & (ml)
Table 71. Europe NEU3 Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa NEU3 Antibody Sales Forecast by Country (2024-2029) & (ml)
Table 73. Middle East & Africa NEU3 Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global NEU3 Antibody Sales Forecast by Type (2024-2029) & (ml)
Table 75. Global NEU3 Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global NEU3 Antibody Sales Forecast by Application (2024-2029) & (ml)
Table 77. Global NEU3 Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck NEU3 Antibody Product Portfolios and Specifications
Table 80. Merck NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific NEU3 Antibody Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Aviva Systems Biology Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 89. Aviva Systems Biology NEU3 Antibody Product Portfolios and Specifications
Table 90. Aviva Systems Biology NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 91. Aviva Systems Biology Main Business
Table 92. Aviva Systems Biology Latest Developments
Table 93. Biomatik Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 94. Biomatik NEU3 Antibody Product Portfolios and Specifications
Table 95. Biomatik NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 96. Biomatik Main Business
Table 97. Biomatik Latest Developments
Table 98. LifeSpan BioSciences Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 99. LifeSpan BioSciences NEU3 Antibody Product Portfolios and Specifications
Table 100. LifeSpan BioSciences NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 101. LifeSpan BioSciences Main Business
Table 102. LifeSpan BioSciences Latest Developments
Table 103. ProSci Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 104. ProSci NEU3 Antibody Product Portfolios and Specifications
Table 105. ProSci NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 106. ProSci Main Business
Table 107. ProSci Latest Developments
Table 108. Novus Biologicals Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 109. Novus Biologicals NEU3 Antibody Product Portfolios and Specifications
Table 110. Novus Biologicals NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 111. Novus Biologicals Main Business
Table 112. Novus Biologicals Latest Developments
Table 113. OriGene Technologies Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 114. OriGene Technologies NEU3 Antibody Product Portfolios and Specifications
Table 115. OriGene Technologies NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 116. OriGene Technologies Main Business
Table 117. OriGene Technologies Latest Developments
Table 118. Proteintech Group Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 119. Proteintech Group NEU3 Antibody Product Portfolios and Specifications
Table 120. Proteintech Group NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 121. Proteintech Group Main Business
Table 122. Proteintech Group Latest Developments
Table 123. CUSABIO Technology Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 124. CUSABIO Technology NEU3 Antibody Product Portfolios and Specifications
Table 125. CUSABIO Technology NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 126. CUSABIO Technology Main Business
Table 127. CUSABIO Technology Latest Developments
Table 128. Abcam Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 129. Abcam NEU3 Antibody Product Portfolios and Specifications
Table 130. Abcam NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 131. Abcam Main Business
Table 132. Abcam Latest Developments
Table 133. EpiGentek Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 134. EpiGentek NEU3 Antibody Product Portfolios and Specifications
Table 135. EpiGentek NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 136. EpiGentek Main Business
Table 137. EpiGentek Latest Developments
Table 138. Leading Biology Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 139. Leading Biology NEU3 Antibody Product Portfolios and Specifications
Table 140. Leading Biology NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 141. Leading Biology Main Business
Table 142. Leading Biology Latest Developments
Table 143. United States Biological Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 144. United States Biological NEU3 Antibody Product Portfolios and Specifications
Table 145. United States Biological NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 146. United States Biological Main Business
Table 147. United States Biological Latest Developments
Table 148. Creative Diagnostics Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 149. Creative Diagnostics NEU3 Antibody Product Portfolios and Specifications
Table 150. Creative Diagnostics NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 151. Creative Diagnostics Main Business
Table 152. Creative Diagnostics Latest Developments
Table 153. Biobyt Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 154. Biobyt NEU3 Antibody Product Portfolios and Specifications
Table 155. Biobyt NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 156. Biobyt Main Business
Table 157. Biobyt Latest Developments
Table 158. Jingjie PTM BioLab Basic Information, NEU3 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 159. Jingjie PTM BioLab NEU3 Antibody Product Portfolios and Specifications
Table 160. Jingjie PTM BioLab NEU3 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 161. Jingjie PTM BioLab Main Business
Table 162. Jingjie PTM BioLab Latest Developments
List of Figures
Figure 1. Picture of NEU3 Antibody
Figure 2. NEU3 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NEU3 Antibody Sales Growth Rate 2018-2029 (ml)
Figure 7. Global NEU3 Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. NEU3 Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal
Figure 10. Product Picture of Polyclonal
Figure 11. Global NEU3 Antibody Sales Market Share by Type in 2022
Figure 12. Global NEU3 Antibody Revenue Market Share by Type (2018-2023)
Figure 13. NEU3 Antibody Consumed in Immunochemistry (IHC)
Figure 14. Global NEU3 Antibody Market: Immunochemistry (IHC) (2018-2023) & (ml)
Figure 15. NEU3 Antibody Consumed in Immunofluorescence (IF)
Figure 16. Global NEU3 Antibody Market: Immunofluorescence (IF) (2018-2023) & (ml)
Figure 17. NEU3 Antibody Consumed in Immunoprecipitation (IP)
Figure 18. Global NEU3 Antibody Market: Immunoprecipitation (IP) (2018-2023) & (ml)
Figure 19. NEU3 Antibody Consumed in Western Blot (WB)
Figure 20. Global NEU3 Antibody Market: Western Blot (WB) (2018-2023) & (ml)
Figure 21. NEU3 Antibody Consumed in ELISA
Figure 22. Global NEU3 Antibody Market: ELISA (2018-2023) & (ml)
Figure 23. NEU3 Antibody Consumed in Others
Figure 24. Global NEU3 Antibody Market: Others (2018-2023) & (ml)
Figure 25. Global NEU3 Antibody Sales Market Share by Application (2022)
Figure 26. Global NEU3 Antibody Revenue Market Share by Application in 2022
Figure 27. NEU3 Antibody Sales Market by Company in 2022 (ml)
Figure 28. Global NEU3 Antibody Sales Market Share by Company in 2022
Figure 29. NEU3 Antibody Revenue Market by Company in 2022 ($ Million)
Figure 30. Global NEU3 Antibody Revenue Market Share by Company in 2022
Figure 31. Global NEU3 Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global NEU3 Antibody Revenue Market Share by Geographic Region in 2022
Figure 33. Americas NEU3 Antibody Sales 2018-2023 (ml)
Figure 34. Americas NEU3 Antibody Revenue 2018-2023 ($ Millions)
Figure 35. APAC NEU3 Antibody Sales 2018-2023 (ml)
Figure 36. APAC NEU3 Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Europe NEU3 Antibody Sales 2018-2023 (ml)
Figure 38. Europe NEU3 Antibody Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa NEU3 Antibody Sales 2018-2023 (ml)
Figure 40. Middle East & Africa NEU3 Antibody Revenue 2018-2023 ($ Millions)
Figure 41. Americas NEU3 Antibody Sales Market Share by Country in 2022
Figure 42. Americas NEU3 Antibody Revenue Market Share by Country in 2022
Figure 43. Americas NEU3 Antibody Sales Market Share by Type (2018-2023)
Figure 44. Americas NEU3 Antibody Sales Market Share by Application (2018-2023)
Figure 45. United States NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC NEU3 Antibody Sales Market Share by Region in 2022
Figure 50. APAC NEU3 Antibody Revenue Market Share by Regions in 2022
Figure 51. APAC NEU3 Antibody Sales Market Share by Type (2018-2023)
Figure 52. APAC NEU3 Antibody Sales Market Share by Application (2018-2023)
Figure 53. China NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. India NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe NEU3 Antibody Sales Market Share by Country in 2022
Figure 61. Europe NEU3 Antibody Revenue Market Share by Country in 2022
Figure 62. Europe NEU3 Antibody Sales Market Share by Type (2018-2023)
Figure 63. Europe NEU3 Antibody Sales Market Share by Application (2018-2023)
Figure 64. Germany NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. France NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa NEU3 Antibody Sales Market Share by Country in 2022
Figure 70. Middle East & Africa NEU3 Antibody Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa NEU3 Antibody Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa NEU3 Antibody Sales Market Share by Application (2018-2023)
Figure 73. Egypt NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country NEU3 Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of NEU3 Antibody in 2022
Figure 79. Manufacturing Process Analysis of NEU3 Antibody
Figure 80. Industry Chain Structure of NEU3 Antibody
Figure 81. Channels of Distribution
Figure 82. Global NEU3 Antibody Sales Market Forecast by Region (2024-2029)
Figure 83. Global NEU3 Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global NEU3 Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global NEU3 Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global NEU3 Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global NEU3 Antibody Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のNEU3抗体市場予測 2023年-2029年] (コード：LP23DC08024)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のNEU3抗体市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアンギオテンシノーゲン抗体市場予測 2023年-2029年
  • 世界のホスホセリン抗体市場予測 2023年-2029年
  • 世界のアンギオテンシノーゲンモノクローナル抗体市場予測 2023年-2029年
  • 世界の抗ロドプシンモノクローナル抗体市場予測 2023年-2029年
  • 世界のAGK抗体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆